Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.340
+0.004 (1.04%)
At close: Jul 19, 2024, 4:00 PM
0.338
-0.002 (-0.44%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
Asensus Surgical Market Cap
Asensus Surgical has a market cap or net worth of $92.55 million as of July 22, 2024. Its market cap has decreased by -18.60% in one year.
Market Cap
92.55M
Enterprise Value
88.54M
1-Year Change
-18.60%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since December 1, 1998, Asensus Surgical's market cap has increased from $12.10M to $92.55M, an increase of 664.90%. That is a compound annual growth rate of 8.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 92.60M | 9.85% |
Dec 29, 2023 | 84.30M | 2.55% |
Dec 30, 2022 | 82.20M | -68.41% |
Dec 31, 2021 | 260.20M | 316.99% |
Dec 31, 2020 | 62.40M | 115.92% |
Dec 31, 2019 | 28.90M | -94.08% |
Dec 31, 2018 | 488.40M | 27.02% |
Dec 29, 2017 | 384.50M | 157.02% |
Dec 30, 2016 | 149.60M | -39.77% |
Dec 31, 2015 | 248.40M | 35.15% |
Dec 31, 2014 | 183.80M | -33.86% |
Dec 31, 2013 | 277.90M | 2,497.20% |
Dec 31, 2012 | 10.70M | -36.31% |
Dec 30, 2011 | 16.80M | -64.71% |
Dec 31, 2010 | 47.60M | 111.56% |
Dec 31, 2009 | 22.50M | 4.65% |
Dec 31, 2008 | 21.50M | -70.95% |
Dec 31, 2007 | 74.00M | 1,056.25% |
Dec 29, 2006 | 6.40M | -33.33% |
Dec 30, 2005 | 9.60M | 405.26% |
Dec 31, 2004 | 1.90M | 5.56% |
Dec 31, 2003 | 1.80M | 12.50% |
Dec 31, 2002 | 1.60M | -69.23% |
Dec 31, 2001 | 5.20M | -18.75% |
Dec 29, 2000 | 6.40M | -63.84% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Checkpoint Therapeutics | 96.44M |
Anixa Biosciences | 94.10M |
Aclaris Therapeutics | 94.07M |
111, Inc. | 93.71M |
Assembly Biosciences | 93.29M |
LakeShore Biopharma | 92.26M |
Eupraxia Pharmaceuticals | 91.19M |
Cellectar Biosciences | 90.34M |